Boston Scientific Corporation Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Boston Scientific Corporation's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Contents

• 1 List of Tables
  • 1.2 List of Figures
• 2 Company Snapshot
  • 2.1 Key Information
  • 2.2 Company Overview
  • 2.3 Financial Performance
  • 2.4 Industry Outlook - Cardiovascular Devices
  • 2.5 Industry Outlook - Endoscopy Devices
  • 2.6 Industry Outlook - Hospital Supplies
• 3 Business Description
  • 3.1 Business Overview
  • 3.2 Cardiovascular
  • 3.3 Endosurgery
  • 3.4 Neuromodulation
  • 3.5 Major Products and Services
• 4 History
• 5 Business Strategy
  • 5.1 Mission Statement
  • 5.2 Strategy
  • 5.3 Corporate Social Responsibility
• 6 Value Chain Analysis
  • 6.1 Manufacturing
  • 6.2 Product Development
  • 6.3 Sales and Marketing
• 7 Competitors
• 8 Share Holding Structure
• 9 Key Employees
• 10 Key Employee Biographies
• 11 Company Statement
• 12 Locations And Subsidiaries
  • 12.1 Head Office
  • 12.2 Other Locations & Subsidiaries
• 13 Recent Developments
  • 13.1 Strategy And Business Planning
  • 13.2 Financial Announcements
  • 13.3 Corporate Communications
  • 13.4 Legal and Regulatory
  • 13.5 Product News
  • 13.6 Product Approvals
  • 13.7 Clinical Trials
  • 13.8 Other Significant Developments
• 14 Boston Scientific Corporation Pipeline Products
  • 14.1 Boston Scientific Corporation Product Pipeline Analysis
  • 14.2 TAXUS Element Stent System
  • 14.3 Odyssey
  • 14.4 TAXUS Liberte Long Stent
  • 14.5 TAXUS Liberte SR Stent System
  • 14.6 TAXUS Paclitaxel-Eluting Coronary Stent in women
  • 14.7 TAXUS Express2 moderate-release paclitaxel-eluting stent
  • 14.8 Taxus Paclitaxel Drug Eluting Stent System For Saphenous Vein Graft
  • 14.9 Acuity Lead Delivery System
  • 14.10 VITALITY NXT Defibrillator
  • 14.11 Cryo Balloon Catheter
  • 14.12 Taxus Stent 4mm
  • 14.13 TAXUS Liberte Paclitaxel-eluting Coronary Stent System (Diabetes)
  • 14.14 TAXUS Liberte Stent System (AMI)
  • 14.15 TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System
  • 14.16 Taxus Paclitaxel-eluting Coronary Stent (Left Main)
  • 14.17 Apex Monorail PTCA Dilatation Catheter
  • 14.18 Apex Over-The-Wire PTCA Dilation Catheter
  • 14.19 LIVIAN cardiac resynchronization therapy defibrillator
  • 14.20 Next generation everolimus-based stent
  • 14.21 WallFlex Biliary Fully-covered Stent
  • 14.22 Temporary RV VVI pacing
  • 14.23 Cardiac Resynchronization Therapy with Defibrillator
• 15 Appendix
  • 15.1 Methodology
  • 15.2 Contact Us
  • 15.3 About Global Markets Direct
  • 15.4 Disclaimer
• 1 List of Tables
  • Table 1: Boston Scientific Corporation,Key Facts, 2007
  • Table 2: Boston Scientific Corporation, Share Holding Structure
  • Table 3: Boston Scientific Corporation, Key Employees, 2007
  • Table 4: Boston Scientific Corporation, Other Locations
  • Table 5: Boston Scientific Corporation Pipeline Products by Equipment Type
  • Table 6: Boston Scientific Corporation Pipeline Products By Development Stage
  • Table 7: Boston Scientific Corporation Pipeline Products By Therapy Area
  • Table 8: Boston Scientific Corporation Pipeline Products By Clinical Trials
  • Table 9: Boston Scientific Corporation Pipeline Products By News Summaries
  • 1.2 List of Figures
  • Figure 1: Boston Scientific Corporation, Value Chain Analysis
  • Figure 2: Boston Scientific Corporation Pipeline Products By Equipment Type
  • Figure 3: Boston Scientific Corporation Pipeline Products By Equipment Type
  • Figure 4: Boston Scientific Corporation Pipeline Products By Development Stage
  • Figure 5: Boston Scientific Corporation Pipeline Products By Clinical Trials
  • Figure 6: Boston Scientific Corporation Pipeline Products By News Summary
  • Figure 7: Global Markets Direct Methodology